Core Insights - Datavault AI Inc. has appointed Pete Scobell as Vice President of Global Security to enhance its security operations and support its initiatives, including the Anti-Stolen Valor program and the International Elements Exchange launch [1][2][3] Company Developments - The Anti-Stolen Valor initiative aims to honor military service and promote integrity and accountability within a data-driven ecosystem, aligning with Datavault's mission of merging value creation with national service principles [2] - Scobell's extensive background as a U.S. Navy SEAL veteran is expected to bring discipline and precision to Datavault's operations, particularly in real-world asset logistics [3][4] Strategic Focus - The company emphasizes the importance of moral protection alongside physical security, aiming to set a new global standard for accountability and trust in its operations [4] - Datavault AI is focused on leveraging its cloud-based platform for AI-driven data experiences, valuation, and monetization across various industries, including sports, entertainment, biotech, and fintech [5]

Core Points - Datavault AI Inc. has regained compliance with Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price requirement for its common stock [1][2] - The company's common stock maintained a closing bid price of at least $1.00 per share for ten consecutive trading days from September 26, 2025, to October 9, 2025 [2] - The resolution of this compliance issue highlights Datavault AI's commitment to maintaining its listing status and delivering value to shareholders [3] Company Overview - Datavault AI Inc. specializes in secure data tokenization and Web 3.0 innovations, offering AI-driven data experiences, valuation, and monetization [1][5] - The company operates a cloud-based platform that provides solutions across various industries, including sports & entertainment, biotech, education, fintech, real estate, healthcare, and energy [5] - Datavault AI's technology suite includes patented technologies in its Acoustic Science Division and high-performance computing solutions in its Data Science Division [5]

Core Insights - Datavault AI Inc. has successfully converted long-term notes with an original face value of $13.3 million, significantly strengthening its balance sheet [1][2] - The conversion of these notes is viewed as a strategic milestone that supports the accelerated launch of independent data exchanges (IDEs) and the development of supercomputing capabilities in collaboration with IBM [2] - The company recently secured a $150 million strategic equity investment in Bitcoin from Scilex, a Nasdaq-listed biotech company, which aligns with Datavault AI's focus on the biotech sector as a primary target market [2] Company Overview - Datavault AI is a leader in AI-driven data experiences, focusing on the valuation and monetization of assets within the Web 3.0 environment [3] - The company's cloud-based platform offers comprehensive solutions across various industries, including sports & entertainment, biotech, education, fintech, real estate, healthcare, and energy [3] - Datavault AI's technology suite includes patented technologies for audio transmission and high-performance computing solutions for data perception, valuation, and secure monetization [3] - The Information Data Exchange (IDE) enables the creation of Digital Twins and the licensing of name, image, and likeness (NIL), promoting responsible AI practices [3]

Core Viewpoint - Scilex Holding Company has completed the initial tranche of a $150 million investment in Datavault AI Inc., acquiring 15 million shares at an effective price of $0.5378 per share, with potential for additional shares pending stockholder approval [1]. Company Overview - Scilex is focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases [3][5]. - The company targets high unmet needs in the market with its non-opioid therapies, aiming to improve patient outcomes [3]. Commercial Products - Scilex's commercial products include: - ZTlido® (lidocaine topical system) 1.8%, approved for neuropathic pain relief [3]. - ELYXYB®, an FDA-approved oral solution for acute migraine treatment [3]. - Gloperba®, the first liquid oral version of colchicine for gout flare prophylaxis [3]. Product Candidates - Scilex has three product candidates in development: - SP-102 (SEMDEXA), a viscous gel for epidural injections to treat sciatica, which has completed Phase 3 studies and received Fast Track status from the FDA [4]. - SP-103, a next-generation lidocaine topical system for acute pain, recently completed a Phase 2 trial and has also received Fast Track status [4]. - SP-104, a low-dose naltrexone hydrochloride for fibromyalgia treatment [4]. Investment Details - The initial tranche of the investment in Datavault AI Inc. involves the acquisition of 15 million shares, with the potential for up to 278,914,094 shares in total, subject to stockholder approval [1]. - The effective purchase price for the shares is $0.5378, with adjustments possible for stock splits [1].

Core Viewpoint - Datavault AI Inc. clarifies that recent insider stock sales were made to cover tax obligations related to the vesting of incentive share grants, and the reporting officers have not sold any of their shares [1][2]. Company Overview - Datavault AI Inc. (Nasdaq: DVLT) specializes in AI-driven data monetization and operates a cloud-based platform that offers solutions across various industries, including sports, biotech, education, and healthcare [3]. - The company’s technology suite includes patented technologies in its Acoustic Science Division and leverages high-performance computing in its Data Science Division to provide secure monetization and valuation of data [3]. Financial Performance - In Q2 2025, Datavault AI reported recognized revenue of $1.7 million, reflecting a significant year-over-year growth of 467% [7]. - The company also secured a $2.5 million licensing deal with Nyiax during the same quarter [7].

Core Insights - Datavault AI has formed a strategic partnership with Burke Products to support defense and aerospace programs, leveraging Datavault's data technologies and Burke's manufacturing capabilities [1][3][9] - The partnership is expected to generate revenues from existing contracts in 2025 and expand into product offerings by 2026 [1][4] - Global defense spending is projected to exceed $2.2 trillion in 2025, with a focus on secure data solutions and advanced tracking, areas where Datavault AI is positioned to provide innovative solutions [4][9] Company Overview - Datavault AI Inc. specializes in data visualization, valuation, and monetization technologies, with a focus on AI-driven data experiences in the Web 3.0 environment [11] - The company’s technology suite includes patented solutions in acoustic science and data science, aimed at various industries including defense and aerospace [11] - Burke Products is a minority-owned manufacturer with over 59 years of experience in providing high-precision components for the defense sector, maintaining relationships with major clients like Lockheed Martin and Raytheon Technologies [12] Partnership Details - The collaboration will integrate Datavault AI's proprietary technologies, including ADIO® tone technology, into Burke's existing systems, with future phases potentially involving digital twin modeling and blockchain tools [5][9] - The partnership aims to enhance mission-critical systems through innovative solutions in acoustic sciences and secure data management [5][8] - Both companies emphasize a shared vision for scalable, American-built solutions that address complex challenges in the defense sector [8][10]